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Prevalence of epilepsy among people with intellectual disabilities: a systematic review 
Abstract 
Purpose. Epilepsy is more common in people with intellectual disabilities than in the general 
population.  However, reported prevalence rates vary widely between studies.  This systematic 
review aimed to provide a summary of prevalence studies and estimates of prevalence based on 
meta-analyses.    
Method. Studies were identified via electronic searches using Medline, Cinahl and PsycINFO and 
cross-citations.  Information extracted from studies was tabulated.  Prevalence rate estimates were 
pooled using random effects meta-analyses and subgroup analyses were conducted. 
Results.  A total of 48 studies were included in the tabulation and 46 studies were included in meta-
analyses.  In general samples of people with intellectual disabilities, the pooled estimate from 38 
studies was 22.2% (95% CI 19.6-25.1).  Prevalence increased with increasing level of intellectual 
disability.  For samples of people with Down syndrome, the pooled estimate from data in 13 studies 
was 12.4% (95% CI 9.1-16.7), decreasing to 10.3% (95% CI 8.4-12.6) following removal of two studies 
focusing on older people. Prevalence increased with age in people with Down syndrome and was 
particularly prevalent in those with Alzheimer’s/dementia. 
Conclusion.  Epilepsy is highly prevalent in people with intellectual disabilities.  Services must be 
equipped with the skills and information needed to manage this condition. 
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Intellectual disability (often referred to as ‘learning disabilities’ in the United Kingdom) refers to a 
significant general impairment in intellectual functioning that is acquired during childhood, typically 
operationalised as scoring more than two standard deviations below the population mean on a test 
of general intelligence (Einfeld and Emerson, 2008). While estimates of the prevalence of intellectual 
disability vary widely, it has been estimated that approximately 2% of the adult population have 
intellectual disability (Maulik et al., 2011, Hatton et al., 2014).  
In the general population, estimates of the prevalence of epilepsy are in region of 0.6% (Forsgren et 
al., 2005, Ngugi et al., 2010) to 1% (Linehan et al., 2010, Joint Epilepsy Council, 2011).  In people with 
intellectual disabilities, estimates of the prevalence of epilepsy vary due to differences in the 
methods used and inherent population biases (Lhatoo and Sander, 2001).  Reported rates range, for 
example,  from 16.1% of 1,595 people with intellectual disabilities identified in South Wales (Morgan 
et al., 2003) to 30.7% in a random sample of 753 people with intellectual disabilities aged 40 or more 
from Ireland’s National Intellectual Disability Database (NIDD) (McCarron et al., 2014).  In a 
systematic review of the prevalence of chronic health conditions in children with intellectual 
disabilities, the most common condition was epilepsy (Oeseburg et al., 2011) with prevalence rates 
in the 14 studies identified ranging from 5.5% to 35.0%, with an overall weighted mean prevalence 
rate of 22.0% (95% CI 20.8–23.2).   
Despite variation in reported prevalence figures, it is clear that the prevalence of epilepsy in people 
with intellectual disabilities is much greater than in the general population.  Further, for people with 
intellectual disabilities and epilepsy, co-morbidities may be common.  Over half of a representative 
sample of children with intellectual disability and active epilepsy were reported to have a psychiatric 
diagnosis  (Steffenburg et al., 1996).   However, conflicting findings exist and there is no consensus 





morbidity compared to their peers with either epilepsy or intellectual disability alone (Beavis et al., 
2007). 
The prevalence of epilepsy also increases with increasing severity of intellectual disabilities.   In the 
Oeseburg et al (2011) review, the lower rate of 5.5% was for children with borderline to moderate 
intellectual disability (Dekker and Koot, 2003), whilst the rate of 35.0% was for children with mild to 
profound intellectual disability (Koskentausta et al., 2002).  Such wide differences highlight the need 
to examine prevalence rates taking into account factors such as the degree of intellectual disability 
of the sample.  Samples based on, for example, those in contact with intellectual disability services 
are likely to miss out some people with less severe intellectual disabilities.   A further issue is that the 
ascertainment of epilepsy is not consistent across studies, both in terms of the definition of epilepsy 
used, and how the information is collected.   
The aim of this review is to summarise existing research on the prevalence of epilepsy in people with 
intellectual disabilities, including studies relating specifically to people with Down syndrome which is 
the most common genetic cause of intellectual disabilities (Sherman et al., 2007).  The review also 
aims to provide pooled prevalence estimates for studies taking into account factors such as age and 
level of intellectual disability.  Whilst existing reviews have considered the prevalence of epilepsy in 
people with intellectual disabilities, these reviews do not cover more recent studies on prevalence 
that now provide more data, particularly in relation to adults with intellectual disabilities.  As 
highlighted in one earlier review, adults have previously been underrepresented in research on the 
epidemiology of epilepsy in people with intellectual disabilities, with the vast majority of published 
data pertaining to children (Lhatoo and Sander, 2001).   As this review aims to estimate epilepsy 
prevalence in the general population of people with intellectual disabilities or Down syndrome, it 
does not include studies relating to less common specific genetic conditions associated with 
intellectual disabilities, although it is evident that work on such conditions has been published 






Electronic literature database searches were conducted in Medline, Cinahl and PsycINFO on EBSCO.  
In addition, the reference lists of articles meeting the inclusion criteria were searched.  The 
reference lists of key book chapters were also searched (Blake and Kerr, 2014, Brown, 2008, Cardoza 
and Kerr, 2010).  Searches were completed on 19 June 2014.  Searches included terms relating to 
both prevalence and mortality to create a pool of articles on prevalence or mortality, with articles on 
mortality being retained for a separate review.  Searches combined terms for epilepsy, intellectual 
disabilities, and prevalence/mortality with the Boolean operator ‘and’.   Full details of the search 
terms are given in Appendix A.   
Inclusion Criteria 
 Peer reviewed 
 English Language full text 
 Published from 1990 
 Primary research 
 Present exact figures on the prevalence of epilepsy  
 Samples where 50% or more have intellectual disabilities or mixed samples where results 
are disaggregated for people with intellectual disabilities 
 Studies using representative samples of people with intellectual disabilities or samples 
representative of specific sub-groups of people with intellectual disabilities (e.g. specific 
level of intellectual disability, specific age band) 
Exclusion Criteria 
 Case studies 






 Studies based on neonates (new born infants up to 28 days after birth)  
 Studies on conditions where intellectual disabilities cannot be assumed (e.g. cerebral palsy) 
where results not disaggregated for people with intellectual disabilities 
 Studies on specific syndromes associated with intellectual disabilities with the exception of 
Down syndrome  
 Studies where ascertainment of epilepsy could be confounded with febrile seizures  
 Studies employing samples unrepresentative of specific sub-groups of people with 
intellectual disability e.g. only those attending for inpatient specialist medical care 
 Studies not presenting exact figures  
Initially, titles and abstracts were used to exclude those studies which were obviously not within the 
scope of reviews on prevalence or mortality.   Those retained for further screening were those for 
which relevance could not be assessed without accessing full text, or those that were chosen as 
potentially within scope. These studies were screened by the first and second author and discussed 
until consensus was reached on whether or not they met the inclusion criteria.  Those relevant to 
other future planned reviews (e.g. mortality) were filed for future reference.   
Where multiple articles used the same sample or samples were likely to have considerable overlap, 
only the most recent study was included.  One exception was a study based on adults with 
intellectual disabilities registered with the Leicestershire Intellectual Disability Register for the 
period 1993-2010 which reported a prevalence of 19.1% in a sample of 5,391 (Kiani et al., 2014).   As 
this study focuses on sudden and unexpected death in epilepsy (SUDEP), it does not outline the 
methodology for obtaining this estimate.  As such, it was decided to include an earlier study based 
on the same register which focused on epilepsy prevalence (McGrother et al., 2006).  A further study  
including only people with Down syndrome which was partly based on the Leicestershire Intellectual 





Information from the included studies was extracted by the first author and this information was 
tabulated (see Table One).   
Quality Assessment 
A gold standard to evaluate the quality of observational research does not exist (Shamliyan et al., 
2010).  A method for evaluating aspects of quality considered important in relation to obtaining valid 
estimates of the prevalence of epilepsy was developed.  The selected quality indicators were:  
1.  Definition of epilepsy: 
 Score 2:  Definition given (e.g. ILAE) 
 Score 1: Partial definition given - some information (e.g. database codes used, epilepsy 
diagnosis) but incomplete 
 Score 0: Not stated (no criteria for epilepsy given) 
2.  Ascertainment of epilepsy – this refers to the identification of those in the sample with epilepsy 
and not any subsequent follow up of those identified as having possible epilepsy.  The following 
scores were allocated: 
 Score 1: Questionnaire self-completion by informant 
 Score 2: Interview with informant 
 Score 3: Extracted from records or databases 
 Score 4: Clinical examination 
If multiple methods were used, the highest level was entered as the score. 
3.  Prevalence figures presented for subgroup(s).  A score of 1 was allocated for each of the following 







 Level of intellectual disability  
 Other – prevalence for other subgroup(s) given (e.g. those with dementia) 
A score was awarded if the information was presented in a bar chart, or in an alternative format 
such as relative risk.  Scores could range from 0 to 4.   Studies were not excluded based on quality 
scores and scores are presented in the first column of Table One.   
Meta-analysis 
For each study, the sample size and number of cases of epilepsy in the sample were entered as 
effect size data in Comprehensive Meta-Analysis Version 2.2 software (www.Meta-Analysis.com).  
Prevalence estimates were pooled using random effects meta-analysis.  For the main random effects 
pooled estimates, heterogeneity between studies was summarised using I2 and Q statistics.   
Subgroup analyses were conducted using between study moderator variables and within study 
subgroups.  To compare across subgroups, the Q-test was used.  Statistical significance was set at p 
value < .05.   
 
Results 
The process of identifying studies for inclusion is summarised in Appendix B.  Electronic database 
searches identified a total of 1,332 references, with 1,099 remaining after removal of duplicates. 
Following the first examination of studies, 144 remained in a pool of articles relating to prevalence 
or mortality.  After examination of full text articles from this pool and the addition of articles cited 
within these, 48 articles met the criteria for inclusion in relation to the prevalence of epilepsy and 
these are summarised in Table One.  Studies only including people with Down syndrome are 






The majority of studies (42) were from high income countries, with just six studies from Low and 
Middle Income countries.  The studies included a wide range of countries, with the greatest number 
for one country being seven studies from the United States (Jelliffe-Pawlowski et al., 2003, 
McDermott et al., 2005, Murphy et al., 1995, Schieve et al., 2012, Schieve et al., 2009, Pueschel et 
al., 1991, Roizen et al., 2014).   
A large number were from European countries: five were from England (Gittins and Rose, 2008, 
McGrother et al., 2006, Pawar and Akuffo, 2008, Collacott, 1993, Prasher, 1995); four from Ireland 
(McBrien and Macken, 2009, McCarron et al., 2014, McCarron et al., 2005, Tyrrell et al., 2001); four 
from Sweden (Fernell, 1998, Forsgren et al., 1990, Nordin and Gillberg, 1996, Steffenburg et al., 
1995); three from Finland (Airaksinen et al., 2000, Arvio and Sillanpää, 2003, Koskentausta et al., 
2002); three from the Netherlands (Dekker and Koot, 2003, van Schrojenstein Lantman-de Valk et 
al., 1997, van Schrojenstein Lantman-De Valk et al., 2000); two from Wales (Matthews et al., 2008, 
Morgan et al., 2003); two from Norway (Hove and Havik, 2010, Strømme and Hagberg, 2000); one 
study each from Scotland (Goulden et al., 1991), Northern Ireland (McVicker et al., 1994), Bosnia and 
Herzegovina (Memisevic and Sinanovic, 2009), Italy (Benassi et al., 1990), France (David et al., 2014), 
and Denmark (Johannsen et al., 1996);  and one study included 14 European countries (Haveman et 
al., 2011).   
In addition, there were two studies from South Africa (Christianson et al., 2002, Molteno et al., 
2001) and two from Australia (Lewis et al., 2000, Wellesley et al., 1992).  Finally, one study each was 
included from the following countries:  New Zealand (Hand and Reid, 1996); India (Lakhan, 2013); 
Taiwan (Lin et al., 2003); Egypt (Temtamy et al., 1994); Israel (Tenenbaum et al., 2012); Hong Kong 







Studies were almost entirely cross-sectional and based on retrospective review of records, questions 
completed either by self-report or interview, or clinical examination.  There were three prospective 
cohort studies (Airaksinen et al., 2000, Goulden et al., 1991, van Schrojenstein Lantman-de Valk et 
al., 1997) although in the latter authors only present prevalence rates for the last data collection 
round. In one retrospective study people could be included in more than one age-band estimate as 
there was an average of 12 years of follow-up for those with disabilities (McDermott et al., 2005).    
Table One here: Summary of studies 
Meta-analysis 
Two studies were excluded from meta-analyses as they focused on seizures in the last 12 months 
rather than epilepsy per se (Schieve et al., 2012, Schieve et al., 2009). For prospective or 
retrospective cohort studies where people could be included in prevalence estimates at more than 
one time point, only the most recent data collection point was included.  Analyses looked at 
subgroups using between study moderator variables, and also within study subgroups.   
Table Two Here 
General Samples versus Samples of people with Down syndrome 
An a priori decision was taken to compare studies based solely on samples of people with Down 
syndrome to general samples of people with intellectual disabilities.  This was done in view of 
evidence suggesting that the prevalence of epilepsy is lower in people with Down syndrome than in 
general samples of people with intellectual disabilities (although these general sample figures are 
likely to include a number of people with Down syndrome).  Whether or not studies included only 
people with Down syndrome was used as a between study moderator variable (see Table Two).  The 





(95% CI 19.6 - 25.1).  There was significant heterogeneity between the studies (I2= 96.4%, Q = 
1025.2, df =37, P < .001). The pooled estimate for studies including only people with Down 
syndrome was 13.6% (95% CI 9.9 to 18.4).  There was significant heterogeneity between studies (I2= 
91.7%, Q = 84.3, df = 7, p < .001).   Figure one presents a forest plot of the 38 studies based on 
general samples and the 8 studies based on samples of people with Down syndrome only. 
Figure One Here 
Level of intellectual disability 
For studies using general samples of people with intellectual disabilities, level of intellectual 
disability was used as a between study moderator variable (see Table Two).  This classified studies 
as: ‘All’ (study representative of all levels of intellectual disability); ‘Less’ (study representative of 
those with less severe intellectual disabilities e.g. excludes those with severe/profound intellectual 
disability); ‘More’ (study representative of those with more severe intellectual disabilities e.g. 
excludes those with mild intellectual disability).   The pooled estimate for studies including all levels 
of intellectual disability was 22.2% (95% CI 19.6-25.0), whereas the estimate for studies classed as 
‘less severe’ was 7.3% (95% CI 4.5-11.6) and the estimate for ‘more severe’ 41.6% (95% CI 32.1-
51.8).  In view of the effect of level of intellectual disability on pooled prevalence estimates, 
subsequent analyses only included those 29 studies which included all levels of intellectual disability.   
Age Group 
Broad age group was used as a between study moderator variable for the 29 studies which included 
all levels of intellectual disability and which were not restricted to people with Down syndrome. Age 
group was classed as adult, child, or mixed (adult and child).  This was based on the main age group 
of the study sample, so for example a study would be classed as ‘adult’ if it included mainly adults 





children and a small number of 20 year olds.   Estimates for these broad age groups did not differ 
significantly (see Table Two).   
Country Economy 
Country economy (High or Low and Middle Income (LAMI)) was also used as a between study 
moderator variable for the 29 studies which included all levels of intellectual disability and which 
were not restricted to people with Down syndrome.   Countries in which studies were undertaken 
were classed as ‘high income’ or ‘low and middle income’ based on the World Bank list of economies 
(World Bank, 2014).  This classifies countries according to 2013 gross national income (GNI) per 
capita: low income, $1,045 or less; lower middle income, $1,046–4,125; upper middle income, 
$4,126–12,745; and high income, $12,746 or more.  Taiwan (not included in country classification) 
was classed as High Income.   One study included 14 European countries of which one was upper 
middle income and this study overall was classed as ‘high income’ (Haveman et al., 2011).  There 
was no significant difference in the pooled estimates (see Table Two). 
Within study subgroup analyses 
Further meta-analyses were then conducted which included information on prevalence from within 
study subgroups, for example where studies presented prevalence rates separately by level of 
intellectual disability, gender or age bands.  Studies which only included a relevant subgroup (e.g. a 
sample including only people with mild intellectual disability) were also included in these analyses.   
Level of intellectual disability 
For level of intellectual disability, firstly prevalence rates were included for those with mild 
intellectual disability and the combined prevalence for those with moderate, severe or profound 
intellectual disability.  Combining moderate, severe and profound intellectual disability was done to 
maximise the number of studies that could be included as few studies presented results for each of 





moderate/severe/profound intellectual disability from 14 studies was 30.4% (95% CI 25.5-35.7) 
compared to 9.8% (95% CI 7.6-12.4) from 13 studies for those with mild intellectual disability.  See 
Figure Two. 
Figure Two: Forest plot for prevalence mild versus moderate/severe/profound intellectual disability 
here 
 
Pooled estimates were also calculated for the studies which did provide separate estimates for any 
of the moderate, severe or profound categories.  For moderate intellectual disability, the pooled 
estimate was 16.7% (95% CI 10.8-25.0), compared to 27.0% (95% CI 16.1-41.5) for severe intellectual 
disability and 50.9% (95% CI 36.1-65.5) for profound intellectual disability. 
Gender 
Where male and female prevalence figures were given separately, pooled estimates were male 
24.8% (95% CI 19.6-30.8) and female 22.2% (17.3-28.1).  One study in the male/female subgroup 
analysis only included those with mild or moderate intellectual disability but was nonetheless 
included in the analysis (Memisevic & Sinanovic (2009)) 
 
Age Group 
Studies presenting results separately for age bands were considered using age band as a subgroup 
within study.  Studies presenting results for only one age band were also included in this analysis.  
The broad age bands used were 0-18, 19-49, and 50+.  However, a 5 year leeway was given for these 
age bands at both the upper and lower limit so, for example, a figure for those aged 19-54 or 17-54  
would be included in the 19-49 category.  Age bands from McDermott et al (2005) were not included 
as due to participants having an average of 12 years of follow-up time a person could be in more 





age 22) were included in the appropriate age band.  Overall, there was not a significant difference by 
age band although the prevalence for age band 19-49 (26.0% (95% CI 21.2-31.5)) was slightly higher 
than that for the 0-18 age band (21.6% (95% CI 17.9-25.9) and the 50+ age group (21.5% (95% CI 
17.0-26.9).   
Table Three Here 
Down syndrome 
Eight studies focussed exclusively on people with Down syndrome (Collacott, 1993, Johannsen et al., 
1996, McCarron et al., 2005, McVicker et al., 1994, Prasher, 1995, Pueschel et al., 1991, Roizen et al., 
2014, Tyrrell et al., 2001).  A further eight studies included some results disaggregated for people 
with Down syndrome in the overall sample.  Results from meta-analyses in relation to people with 
Down syndrome are given in Table Three.  In these analyses, prevalence rates from studies looking 
only at people with Down syndrome were combined with prevalence rates given in other studies 
which presented results for people with Down syndrome as a within study subgroup (excluding 
studies which did not include all levels of intellectual disability).  No rates disaggregated by gender 
were identified.   
Firstly, pooled prevalence for people with Down syndrome was estimated by combining the 
prevalence rates from studies looking only at people with Down syndrome with prevalence rates for 
people with Down syndrome presented as a within study subgroup (excluding studies which did not 
include all levels of intellectual disability).  The pooled estimate was 12.4% (95% CI 9.1-16.7).  There 
was significant heterogeneity between studies, I2 = 87.4%, Q = 95.3, df = 12, p < .001.  
Pooled prevalence was also estimated for age bands.  This showed a significant effect of age band, 
with the pooled estimate rising from 6.9% (95% CI 3.8-12.0) at age 0-18, to 9.0% (95% CI 5.9-13.5) at 





In view of the increased rate of epilepsy in older people with Down syndrome, overall prevalence 
was then estimated excluding two studies which looked at samples of people with Down syndrome 
aged 35+ only (Tyrrell et al., 2001, McCarron et al., 2005).  Based on data from 11 studies, the 
pooled estimate was 10.3% (95% CI 8.4-12.6), I2 = 57.0%, Q = 23.2, df =10, p < .01.  However, it 
should be noted that these studies did not include all age bands, with some including only adults and 
other including only children.   
Finally, a small number of studies presented prevalence rates separately for those with and without 
Alzheimer’s disease/dementia.  The pooled prevalence for those with Alzheimer’s/dementia was 
53.3% (95% CI 41.9-64.4) compared to 12.8% (95% CI 7.7-20.4) for those specifically noted not to 
have Alzheimer’s/dementia.  It is not possible to give the mean age for those with and without 
Alzheimer’s disease/dementia overall.  However, the mean age for both groups is available in two 
studies: 54.7 (SD 7.5) for those with Alzheimer’s disease/dementia compared to 45.6 (SD 7.3) for 
those without (Tyrrell et al., 2001); and 55.4 (SD 7.0) for those with and 50.8 (SD 5.8) for those 
without (McCarron et al., 2005).    See Figure Three. 
Figure Three: Forest plot for prevalence by Alzheimer’s/dementia for people with Down syndrome 
here 
Co-morbidity 
A number of studies presented data on co-morbidities in people with intellectual disabilities and 
epilepsy. 
Psychiatric and Behavioural Problems 
One study reported that epilepsy was associated with higher levels of psychopathology (Molteno et 
al., 2001) and one study (controlling for age, gender and level of understanding) found associations 
with epilepsy and some psychological and behaviour problems (McGrother et al., 2006).  However, 
other studies found that people with intellectual disability and epilepsy were not more likely to have 





epilepsy.  Reported findings include: being significantly less likely to have behavioural disturbances 
(17.6% vs 27.9%) (Arvio and Sillanpää, 2003); no significant difference in the prevalence of 
psychiatric  disorders (Koskentausta et al., 2002);  no significant differences in behavioural and 
emotional disturbance when controlling for level of intellectual disability (Lewis et al., 2000); no 
significant differences in psychopathology between matched epilepsy and non-epilepsy groups  
(Matthews et al., 2008); no association between epilepsy and mental health concerns, with 46.7% of 
those with epilepsy reporting mental health problems compared with 48.1% of those without 
epilepsy (McCarron et al., 2014); no association between epilepsy and the prevalence of challenging 
behaviour or psychiatric conditions (Pawar and Akuffo, 2008); and no significant difference in 
maladaptive behaviour scores for those with Down syndrome and epilepsy (Prasher, 1995) 
 
Physical impairments 
People with intellectual disabilities and epilepsy were found to have more associated impairments 
(2.7) than those without epilepsy (1.2) and were more likely to have: speech handicap (73.6% versus 
50.0%), motor handicap (54.4% versus 14.4%), and blindness (14.2% versus 1.4%) (Arvio and 
Sillanpää, 2003).    Other reported co-morbidities in those with epilepsy were:  cerebral palsy (33.4%) 
and visual impairment (12.4%) (Forsgren et al., 1990); cerebral palsy (36.4%) (Goulden et al., 1991); 
and cerebral palsy (43%) and visual impairment (24.5%) (Steffenburg et al., 1995).  After adjusting 
for age, gender and level of understanding, those with epilepsy were more likely to have: a range of 
physical disabilities  (adjusted OR 1.8, 95% CI 1.5-2.2); problems with wetting (OR 2.7, 95% CI 2.1-
3.4), soiling (OR 2.2, 95% CI 1.6-3.1) and walking (OR 2.5, 95% CI 2.0-3.2) (McGrother et al., 2006).  
Those with intellectual disability were also found to be more likely to have joint disease (29.3% 
versus 16.8% for those with intellectual disability without epilepsy, adjusted OR 2.1, 95% CI 1.5-3.1), 
gastrointestinal disease (34.5% versus 23.4%, adjusted OR 1.8, 95% CI 1.3-2.5), and stroke (5.2% 







Despite the variation in reported prevalence rates between studies, it is clear that the prevalence of 
epilepsy is high in people with intellectual disabilities worldwide.  The results suggest that in general 
samples of people with intellectual disabilities, approximately one in five people will have epilepsy, 
with the pooled estimate from 38 studies being 22.2% (95% CI 19.6-25.1).  For samples of people 
with Down syndrome excluding two studies focusing on older people, the rate is lower with 
approximately one in ten people having epilepsy, with the pooled estimate from data in 11 studies 
being 10.3% (95% CI 8.4-12.6).  In studies where this information was available, those with 
intellectual disabilities and epilepsy had more physical impairments than those without epilepsy.  
However, whilst psychiatric or behavioural co-morbidity was common, rates were not necessarily 
higher than in those with intellectual disabilities without epilepsy.  A review specifically addressing 
co-morbidity in people with intellectual disabilities and epilepsy extending beyond studies that 
present figures on prevalence (e.g. Arshad et al., 2011) would be a useful addition to the literature.         
The prevalence of epilepsy is related to level of intellectual disability.  In 29 studies which included 
all levels of intellectual disability, the pooled estimate was 22.2% (95% CI 19.6-25.0), whilst for four 
studies with samples skewed towards less severe intellectual disability the pooled estimate was 
7.3% (95% CI 4.5-11.6) and for five studies skewed towards more severe intellectual disability the 
pooled estimate was 41.6% (95% CI 32.1-51.8).  Similarly, data from 13 studies gives a pooled 
estimate for those with mild intellectual disability of 9.8% (95% CI 7.6-12.5) compared to 30.4% (95% 
CI 25.5-35.7) for those with moderate, severe or profound intellectual disability.  Few studies give 
figures separately for those with moderate, severe or profound intellectual disability but it is clear 
that prevalence increases with level of intellectual disability.  The pooled estimate for moderate 
intellectual disability from five studies was 16.7% (95% CI 10.8-25.0), for severe intellectual disability 
from three studies 27.0% (95% CI 16.1-41.5) and for profound intellectual disability from four studies 





Age was not found to be a significant factor for general samples of people with intellectual 
disabilities, although the rate for those aged 19-49 was slightly higher at 26.0% (95% CI 21.2-31.5) 
than for 0-18 year olds (21.6%, 95% CI 17.9-25.9) and 50+ year olds (21.5%, 95% CI 17.0-26.9).  
However, for people with Down syndrome there was a clear increase in prevalence with age.  Data 
from two studies for those aged 0-18 gave a pooled estimate of 6.9% (95% CI 3.8-12.0), compared to 
9.0% (95% CI 5.9-13.5) for three studies giving data for 19-49 year olds and 26.0% (95% CI 16.1-39.2) 
for three studies giving data for those aged 50 or more.  An increase with age was also found for 
people with Down syndrome in a study by van Schronjenstein et al (1997), with the rates being 4.9% 
at age 0-19, rising to 36.4% for those age 60 or more.  However, it was not possible to include these 
figures in the meta-analysis as sample sizes for individual age bands were not identified.   Similarly, 
an increasing prevalence of epilepsy with age was found for a small sample of people with Down 
syndrome (McDermott et al., 2005)  but these figures could not be included in the meta-analysis due 
to participants being included in more than one age band estimate depending on the number of 
years the person was followed up for.   
Overall, it is clear that for people with Down syndrome, epilepsy prevalence increases with age. This 
increase is likely to be mainly accounted for by the increasing presence of Alzheimer’s 
disease/dementia in people with Down syndrome as they age.  The pooled estimate for those with 
Alzheimer’s disease/dementia from four studies was 53.3% (95% CI 41.9-64.4) compared to 12.8% 
(95% CI 7.7-20.4) for two studies explicitly giving data for those without Alzheimer’s/dementia. 
Further, in one study, epilepsy was found here to be significantly more common in persons at end-
stage (84.0%) versus persons at mid-stage Alzheimer’s disease (39.4%) (McCarron et al., 2005).   
 Limitations 
There are a number of limitations to this review.  Whilst studies were identified from a large range of 
countries, the review is restricted to English language publications.  All data was extracted by one 





of errors.  In some instances it was necessary to calculate figures from reported data as they were 
not reported explicitly (e.g. obtaining the number of epilepsy cases from the overall sample number 
and reported prevalence rate or vice versa) and two minor discrepancies arose.  Firstly, calculating 
figures from McVicker et al (1994) on prevalence by age band resulted in a total number of epilepsy 
cases of 19 compared to a reported number of 18.  Secondly, calculating figures from Wong (2011) 
on prevalence in a subgroup with Down syndrome resulted in a prevalence rate of 13.1% compared 
to a rate of 13.2% as reported in the article.       
Ideally, the same definition of epilepsy should be used across studies to allow comparison of 
prevalence rates (Forsgren et al., 2005).  However, many of the studies identified did not present a 
definition of epilepsy, generally referring to either a diagnosis of epilepsy or the presence of 
epilepsy.  The lack of detail given regarding the definition of epilepsy in many studies means that it is 
not possible to determine whether reported prevalence rates related to active epilepsy or lifetime 
epilepsy.  The issue of defining epilepsy is not straightforward (Fisher et al., 2014).  Where 
definitions were provided, these included standard definitions based on International League 
Against Epilepsy (ILAE) criteria and other definitions specifying variable criteria in relation to number 
of seizures, anti-epileptic drug (AED) use and time spans.  In addition, the source of information used 
to ascertain epilepsy is variable between studies which may lead to varying levels of accuracy in 
obtained rates.   
In addition to the variation in prevalence rates that is likely to be due to differences in the definition 
of epilepsy used and the source of data in studies, there is also likely to be an unknown number of 
cases where epilepsy has been misdiagnosed due to the misinterpretation of behavioural, 
physiological, syndrome related, medication related or psychological events by parents, paid carers 
and health professionals (Chapman et al., 2011).    
Finally, the review has focussed on prevalence in the general population of people with intellectual 





Fragile X syndrome.  Future review work could consider prevalence in a greater range of specific 
syndromes associated with intellectual disabilities.   
 
Conclusion 
This review aims to provide an up to date summary of research on the prevalence of epilepsy in 
people with intellectual disabilities.  The pooling of estimates from studies, and the examination of 
factors which account for some of the heterogeneity of reported prevalence rates between studies, 
allows for the provision of more robust figures on prevalence.  With around one in five people with 
intellectual disabilities having epilepsy, it is important that services are equipped with the 
information and skills needed to manage epilepsy in this population.  A recent report provides 
information on reasonable adjustments that can be made to improve epilepsy care for people with 
intellectual disabilities (Marriott et al., 2014)   The ideas, information and examples of good practice 
in relation to reasonable adjustments provided within this report should help services improve 
provision for this highly prevalent condition.   
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Table One: Summary of Included Studies giving Prevalence Rates for Epilepsy in People with Intellectual Disabilities. Figures under male, and levels of ID  


































































































































































Children with ID 
born 1969-1972 in 
one province 
followed until age 
22.  CP 11%.  LS 
ns.   
School 
achievement tests 
& social services 
register 
Prevalence 
at age 22 yrs 
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Finland People with SPID. 
DS 14.3%, AE 
19.3%,  FXS 
3.9%.  LS ns 
Register of District 
Centre for ID (all 
in catchment) 
1-72 (ns; ns) ns - - - 52.5 47.5 - ns assume 
medical 
records 
Epilepsy, ns DS, 30%  
AE 83% 
FXS 5.5% 




et al (1990)  
 
3 (0/3/0) 
Italy Children with 
‘severe’ ID (IQ 
<=50).  DS 22.2%.  
LS ns. 
System recording 
all school age 
children with ID 





Epilepsy, ns ns 27 90 30.0 
                                                          
1
 Presented as Total score (epilepsy definition score/ascertainment of epilepsy score/subgroup analysis score) 
2





































































































































































Children with ID  
in  rural 
households, up to 
IQ 80.  DS 2.1%, 
CP 8.4% 














Children with mild 
ID born 1997  
living in one 
























moderate ID living 
in family home.  
DS 5.3%.   
Schools for ID 7-20 (12.9 
(3.0); ns) 
61.8 100 ← ← - - - Parent 
interview 





Sweden Children with 
'severe' ID (IQ < 
50-55).  CP 
23.4%, DS 20.3%.  
LS ns. 
Register of Board 
for Provision of 
Services to the 
Mentally Retarded 
BPSMR): all in 
one municipality 







































































































































































Sweden All adults and 
children with ID in 
one County on a 
prevalence day.  
DS 13.7%, Fragile 
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SZ last 5 
yrs &/or on 
AED 
FXS 23.5%, 
DS  5.9% 
RS 80% (4/5) 
  








Adults with PMLD 
in one health 









ns - - - - 100 - Case notes Epilepsy in 
case notes 
ns 39 61 63.9 
Goulden, 
Shinnar, 






Children with ID 
born 1951-1955 
followed to age 
22. CP 14.9%, DS 
5.1%.  LS ns 
Receiving special 
services for ID 




is for age 22  










injury  73.3%, 
Genetic or 
malformation 
eg DS 12.5% 







All NZ older adults 
with ID born 
before 1940, CP 
4%, DS 13%.  LS 
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Multiple agencies 
& local networking 
51-88 (ns; 
ns) 
50.0 4.0 34.5 38.3 15.4 5.1 2.7 Questionnaire 
completed by 
carer, staff or 
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Norway Adults with ID 
living in 
community. DS 
16.4%, CP 9.1%.  
LS includes 
psychiatric wards 
if part of 
community care 
programme 
Social services 18-97 (41.8 
(14.5); ns) 
53.1 - 21.6 41.0 18.0 13.0 6.4 Informant 
questionnaire 
(personnel) 




et al (2003) 
 
5 (1/3/1) 
US Children with ID 
from a larger 
cohort born with or 
without birth 
defects.  CP 
46.8%.  LS ns  

















Finland All children with ID 
born 1982 to 1988 
in one district.  LS 
mostly parental 
home 












































































































































































India Children with ID 
living in village 
households in one 
of poorest 
districts. DS 7.3%, 
CP 31.3% 
Door to door 
survey in 63 
villages 




Epilepsy, ns CP 46.3%, 
DS 10.5% 
62 262 23.7 
Lewis, 
Tonge, 




Australia Young people with 
ID, LS any.   
Services in five 
districts of New 
South Wales 





ns. 115 392 29.3 














61.2 - 4.9 17.4 40.9 24.9 - Parent or 
carer 
questionnaire 
Epilepsy, ns ns 262 1116 23.5a 
Matthews, 
Weston, 




Wales Adults with ID 
registered with 
GP.  LS 
independent 10%, 
family home 46%, 
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Ireland Children with 
moderate, to 
profound ID. Any 
chromosonal or 
genetic cause 
48.5%,  DS 
24.7%.  LS ns 
Centre providing 
educational and 
health services for 
all individuals with 
moderate, severe 
and profound ID in 
one area 
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O'Dwyer, 
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40 - 65+ 
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US Adults  with ID 
receiving primary 
health care.  CP  
24.9%, DS 8.9%.  
LS ns 
Large urban or 






52.0a - 35.9 22.9 41.2 ← - Medical 
records 
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CP  40%  
186a 663 28.1 
McGrother, 
Bhaumik, 
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Children with ID at 
special schools.  
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Morgan, 




Wales  People with ID 
mainly age 16+ in 
contact with health 
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health & social 
services 

































































































































































Sweden All children with ID 
born 1974 to 1988 
in one region. CP 









≥ 1 SZ or 
AED in last 
















Adults with ID in 
contact with 




Adults in contact 




53.7 ns ns ns ns ns 100 Case records Diagnosis 
epilepsy 
ns 53 177 29.9 
Schieve, 
Boulet, Boyle 
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US Children in 
households with 
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National survey of 
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Sweden Children with ID in 
one city born 
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4 (0/4/0) 
Egypt Children with ID in 
households.  DS 
2.6%, MCA 
24.1%, primary 
CNS defect 12.9% 
Households in 
three localities in 
Egypt 
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Tenenbaum, 
Fuchs, 
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People with ID in 
institutions or 
group homes. CP 
11.8%, dementia 
3.8%, DS 22.3% 
Institutions & 
group homes 
0 to 70+ (ns; 
ns) 
ns ns ns ns ns ns 100 GP 
questionnaire 
Epilepsy, ns DS 10.7%, 
non-DS 










et al (1992) 
 
7 (2/3/2) 
Australia Children in 
Western Australia 
with ID born 1967-
1976.   CP 19.8%.  
LS ns  
Multiple services 
& schools 



















Adults with ID in 
residential care.  




 18-79 (44 
(ns); ns) 












Jordan Children at special 
schools for ID.  LS 
ns 
Special education 
















































































































































































Adults with DS, 

























Denmark DS in age groups 
14-16, 23-29 & 
50-60.  LS ns 
All in one County 
identified via 

















Ireland Adults with DS 









ns.  Non-AD  
50.8 (5.8); 
ns) 
33.9 - - 69.4 30.6 - - Medical 
records 






























ns ns ns ns ns ns 100 Medical 
records 
≥ 1 SZ in 
prior 2 yrs 
&/or on 
AED 







































































































































































Cohort with DS in 
West Midlands.   
16-72 (44.2 
(12.5); ns) 
50.7 - 18.9 66.7 13.4 - 1.0 Carer 
interview 
≥ 3 SZ in a 
























Children & adults 
with DS.  LS 






























Children with DS 
in New York State. 
LS ns 
Families 



















Ireland Adults with DS 
over age 35.  








ns - ns ns ns ns 100 Medical notes, 
assessment 
(carer 




65.8%,   
non dementia  
13.5% 
58 283 20.5a 
 
Abbreviations: a = calculated from available figures not reported directly, ns = not stated, SZ = seizures, ILAE = International League Against Epilepsy, AED = anti-





SPID = Severe or profound intellectual disabilities. LS = living situation. CP = cerebral palsy, BPSMR = Board for Provision of Services to the Mentally Retarded, MCA 





Table Two: Random effects meta-analysis pooled estimates of prevalence of epilepsy 
 











Down syndrome     Q 8.7, df 1, p .003 
Mixed sample 38 22.2 19.6 25.1  
Down syndrome only 8 13.6 9.9 18.4  
Level of IDb     
Q 43.4, df 2, 
p<.001 
All 29 22.2 19.6 25.0  
Less severe 4 7.3 4.5 11.6  
More Severe 5 41.6 32.1 51.8  
Agebc     Q 0.8, df 2, p .661 
Adult 12 23.5 19.5 28.0  
Child 12 21.7 17.9 26.1  
Mixed 5 20.2 15.0 26.7  
High/LAMIbc     Q 0.2, df 1, p .626 
High 25 22.4 19.7 25.4  
LAMI 4 20.5 14.5 28.2  
Subgroup (including within 
study subgroups) 
     
Level of ID     Q 56.0, df 1, 
p<.001 
Mild 13 9.8 7.6 12.4  
Moderate/severe/profound 14 30.4 25.5 35.7  
Level of ID (where 
moderate, severe, profound 
available separately) 
 
   
Q 16.6, df 2, 
p<.001 
Moderate 5 16.7 10.8 25.0  
Severe 3 27.0 16.1 41.5  
Profound 4 50.9 36.1 65.5  
Gender (any study where 
male/female figures given 
separately)     
Q 0.4, df 1, p .524 
Male 9 24.8 19.6 30.8  
Female 9 22.2 17.3 28.1  
Age groupsbc     Q 2.2, df 2, p .339 
0-18 11 21.6 17.9 25.9  
19-49 8 26.0 21.2 31.5  
50+ 7 21.5 17.0 26.9  
a Estimates based on meta-
analysis using random 
effects model 
bExcludes DS only studies 
cExcludes less/more severe 
ID studies 






Table Three: Meta-analysis Estimates for people with Down Syndrome  
Subgroup Number 
of studies 








including subgroups in non-
DS only studiesb 13 12.4 9.1 16.7  
Overall prevalence 
including subgroups in non-
DS only studiesb excluding 
two studies on older 
people 11 10.3 8.4 12.6  
Ageb     
Q 15.0, df 2, 
p=.001 
0-18 2 6.9 3.8 12.0  
19-49 3 9.0 5.9 13.5  
50+ 3 26.0 16.1 39.2  
Has Alzheimer’s/dementia     
Q 30.9, df 1, 
p<.001 
Yes 4 53.3 41.9 64.4  
No 2 12.8 7.7 20.4  
a Estimates based on meta-
analysis using random 
effects model 
bExcludes less/more severe 
ID studies 













Study name Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value p-Value
No Airaksinen, Matilainen, Mononen et al (2000) 0.212 0.154 0.284 -6.596 0.000
No Arvio & Sillanpää (2003) 0.518 0.473 0.564 0.792 0.429
No Benassi, Guarino, Cammarata et al (1990) 0.300 0.214 0.402 -3.684 0.000
No Christianson, Zwane, Manga et al (2002) 0.155 0.115 0.207 -9.460 0.000
No David, Dieterich, de Villemeur et al (2014) 0.028 0.012 0.065 -7.852 0.000
No Dekker & Koot (2003) 0.055 0.038 0.079 -14.112 0.000
No Fernell (1998) 0.266 0.172 0.386 -3.593 0.000
No Forsgren, Edvinsson, Blomquist et al (1990) 0.202 0.182 0.223 -21.204 0.000
No Gittins & Rose (2008) 0.639 0.512 0.749 2.147 0.032
No Goulden, Shinnar, Koller et al (1991) 0.153 0.111 0.208 -9.025 0.000
No Hand (1996) 0.167 0.145 0.190 -19.562 0.000
No Haveman, Perry, Salvador-Carulla et al (2011) 0.280 0.256 0.306 -15.003 0.000
No Hove & Havik (2010) 0.226 0.194 0.261 -12.539 0.000
No Jelliffe-Pawlowski, Shaw, Nelson et al (2003) 0.265 0.232 0.302 -11.041 0.000
No Koskentausta, Iivanainen & Almqvist (2002) 0.355 0.284 0.433 -3.561 0.000
No Lakhan (2013) 0.237 0.189 0.292 -8.057 0.000
No Lewis, Tonge, Mowat et al (2000) 0.293 0.250 0.340 -7.925 0.000
No Lin, Wu & Lee (2003) 0.235 0.211 0.261 -16.731 0.000
No Matthews, Weston, Baxter et al (2008) 0.182 0.144 0.229 -10.331 0.000
No McBrien & Macken (2009) 0.361 0.272 0.461 -2.704 0.007
No McCarron, O'Dwyer, Burke et al (2014) 0.307 0.275 0.341 -10.286 0.000
No McDermott, Moran, Platt et al  (2005) 0.281 0.248 0.316 -10.894 0.000
No McGrother, Bhaumik, Thorp et al (2006) 0.259 0.242 0.277 -22.520 0.000
No Memisevic & Sinanovic (2009) 0.204 0.149 0.271 -7.098 0.000
No Molteno, Molteno, Finchilescu et al (2001) 0.237 0.195 0.284 -9.379 0.000
No Morgan, Baxter & Kerr (2003) 0.161 0.144 0.180 -24.225 0.000
No Murphy, Yeargin-Allsopp, Decouflé et al (1995) 0.146 0.126 0.169 -20.434 0.000
No Nordin & Gillberg (1996) 0.218 0.148 0.309 -5.303 0.000
No Pawar & Okuffo (2008) 0.299 0.237 0.371 -5.179 0.000
No Steffenburg, Hagberg, Viggedal et al (1995) 0.259 0.218 0.306 -8.945 0.000
No Strømme & Hagberg (2000) 0.197 0.145 0.262 -7.463 0.000
No Temtamy, Kandil, Demerdash et al (1994) 0.043 0.018 0.099 -6.781 0.000
No Tenenbaum, Fuchs, Raskas et al (2012) 0.327 0.316 0.338 -28.418 0.000
No van Schrojenstein Lantman-de Valk et al (2000) 0.110 0.080 0.149 -11.665 0.000
No van Schrojenstein Lantman-de Valk et al (1997) 0.164 0.142 0.188 -19.272 0.000
No Wellesley, Hockey, Montgomery et al (1992) 0.131 0.115 0.148 -25.463 0.000
No Wong (2011) 0.340 0.309 0.374 -8.931 0.000
No Yousef (1995) 0.198 0.161 0.241 -10.855 0.000
No 0.222 0.196 0.251 -15.273 0.000
Yes Collacott (1993) 0.100 0.072 0.136 -12.352 0.000
Yes Johannsen, Christensen, Goldstein et al (1996) 0.167 0.097 0.271 -5.089 0.000
Yes McCarron, Gill, McCallion et al (2005) 0.339 0.261 0.426 -3.526 0.000
Yes McVicker, Shanks & McClelland (1994) 0.094 0.060 0.145 -9.137 0.000
Yes Prasher (1995) 0.159 0.115 0.216 -8.632 0.000
Yes Pueschel, Louis & McKnight (1991) 0.081 0.059 0.112 -13.337 0.000
Yes Roizen, Magyar, Kuschner et al (2014) 0.068 0.048 0.096 -13.826 0.000
Yes Tyrrell, Cosgrave, McCarron et al (2001) 0.205 0.162 0.256 -9.206 0.000
Yes 0.136 0.099 0.184 -10.031 0.000
Overall 0.178 0.108 0.280 -5.143 0.000










Study name Subgroup within study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value p-Value
Mild Airaksinen, Matilainen, Mononen et al (2000) Mild 0.068 0.028 0.152 -5.667 0.000
Mild Christianson, Zwane, Manga et al (2002) Mild 0.133 0.092 0.189 -8.885 0.000
Mild David, Dieterich, de Villemeur et al (2014) Mild 0.028 0.012 0.065 -7.852 0.000
Mild Forsgren, Edvinsson, Blomquist et al (1990) Mild 0.112 0.084 0.148 -12.665 0.000
Mild Goulden, Shinnar, Koller et al (1991) Mild 0.101 0.063 0.156 -8.566 0.000
Mild Jelliffe-Pawlowski, Shaw, Nelson et al (2003) Mild 0.135 0.102 0.177 -11.315 0.000
Mild Lakhan (2013) Mild 0.038 0.012 0.111 -5.491 0.000
Mild Memisevic & Sinanovic (2009) Mild 0.165 0.100 0.259 -5.552 0.000
Mild Murphy, Yeargin-Allsopp, Decouflé et al (1995) Mild 0.071 0.054 0.091 -18.093 0.000
Mild Steffenburg, Hagberg, Viggedal et al (1995) Mild 0.147 0.107 0.198 -9.605 0.000
Mild Strømme & Hagberg (2000) Mild 0.091 0.048 0.166 -6.586 0.000
Mild Wellesley, Hockey, Montgomery et al (1992) Mild 0.113 0.091 0.141 -16.196 0.000
Mild Yousef (1995) Mild 0.068 0.033 0.136 -6.688 0.000
Mild 0.098 0.076 0.124 -15.943 0.000
MSP Airaksinen, Matilainen, Mononen et al (2000) MSP 0.351 0.253 0.463 -2.580 0.010
MSP Benassi, Guarino, Cammarata et al (1990) MSP 0.300 0.214 0.402 -3.684 0.000
MSP Christianson, Zwane, Manga et al (2002) MSP 0.256 0.148 0.405 -3.055 0.002
MSP Fernell (1998) MSP 0.266 0.172 0.386 -3.593 0.000
MSP Forsgren, Edvinsson, Blomquist et al (1990) MSP 0.233 0.209 0.259 -16.728 0.000
MSP Goulden, Shinnar, Koller et al (1991) MSP 0.348 0.225 0.495 -2.031 0.042
MSP Jelliffe-Pawlowski, Shaw, Nelson et al (2003) MSP 0.411 0.355 0.469 -3.005 0.003
MSP Lakhan (2013) MSP 0.331 0.266 0.404 -4.406 0.000
MSP McBrien & Macken (2009) MSP 0.361 0.272 0.461 -2.704 0.007
MSP Murphy, Yeargin-Allsopp, Decouflé et al (1995) MSP 0.322 0.273 0.375 -6.253 0.000
MSP Steffenburg, Hagberg, Viggedal et al (1995) MSP 0.450 0.370 0.533 -1.181 0.238
MSP Strømme & Hagberg (2000) MSP 0.329 0.235 0.440 -2.974 0.003
MSP Wellesley, Hockey, Montgomery et al (1992) MSP 0.151 0.128 0.178 -17.620 0.000
MSP Yousef (1995) MSP 0.247 0.200 0.302 -7.964 0.000
MSP 0.304 0.255 0.357 -6.706 0.000
Overall 0.179 0.053 0.461 -2.186 0.029














Study name Subgroup within study Statistics for each study Event rate and 95% CI
Event Lower Upper 
rate limit limit Z-Value p-Value
AD/Dementia Collacott (1993) AD/Dementia 0.278 0.121 0.519 -1.816 0.069
AD/Dementia McCarron, Gill, McCallion et al (2005) AD/Dementia 0.556 0.432 0.673 0.880 0.379
AD/Dementia Tyrrell, Cosgrave, McCarron et al (2001) AD/Dementia 0.658 0.496 0.790 1.912 0.056
AD/Dementia McCarron, O'Dwyer, Burke et al (2014) AD/Dementia 0.522 0.325 0.712 0.208 0.835
AD/Dementia 0.533 0.419 0.644 0.565 0.572
Non AD/Dementia McCarron, Gill, McCallion et al (2005) Non AD/Dementia 0.115 0.056 0.222 -5.086 0.000
Non AD/Dementia Tyrrell, Cosgrave, McCarron et al (2001) Non AD/Dementia 0.135 0.097 0.183 -9.940 0.000
Non AD/Dementia 0.128 0.077 0.204 -6.735 0.000
Overall 0.292 0.052 0.755 -0.865 0.387





Appendix A: Electronic Search Strategy 
 
MEDLINE AND CINAHL 
Limits: 1990; English; Human 
(TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or disab* or 
deficien* or handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or handicap*) ) OR 
TI development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI "Down* syndrome" OR 
(MH "Developmental Disabilities/EP/MO") OR (MH "Intellectual Disability+/EP/MO") OR (MH 
"mentally disabled persons")) OR (AB ( learning N1 (disab* or difficult* or handicap*) ) OR AB ( 
mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) OR AB ( intellectual* N1 
(disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB ( multipl* N1 (handicap* 
or disab*) ) OR AB"Down* syndrome") 
AND 
(MH "Epilepsy+/MO/EP") OR ( TI epilep* OR TI seizure* OR TI convulsi* OR AB epilep* OR AB 
seizure* OR AB convulsi*) 
AND 
(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB incidence OR AB prevalence OR AB 
mortality OR AB death) OR (MH "Incidence") OR (MH "Prevalence") OR (MH "Mortality+") 
PSYCINFO 
Limits: 1990, Peer review, English, Exclude dissertations 
DE "Epilepsy" OR DE "Epileptic Seizures" OR (DE "Seizures" OR DE "Audiogenic Seizures" OR DE 
"Epileptic Seizures" OR DE "Grand Mal Seizures" OR DE "Petit Mal Seizures" OR DE "Status 
Epilepticus") OR ( TI epilep* OR TI seizure* OR TI convulsi* OR AB epilep* OR AB seizure* OR AB 
convulsi*) 
AND 
(TI incidence OR TI prevalence OR TI mortality OR TI death OR AB incidence OR AB prevalence OR AB 
mortality OR AB death) OR DE "Epidemiology" OR DE “death and dying” OR DE “mortality rate” 
AND 
DE "Intellectual Development Disorder" OR DE "mental retardation" OR DE "developmental 
disabilities" OR (TI ( learning N1 (disab* or difficult* or handicap*) ) OR TI ( mental* N1 (retard* or 
disab* or deficien* or handicap* or disorder*) ) OR TI ( intellectual* N1 (disab* or impair* or 
handicap*) ) OR TI development* N1 disab* OR TI ( multipl* N1 (handicap* or disab*) ) OR TI 
"Down* syndrome") OR AB ( mental* N1 (retard* or disab* or deficien* or handicap* or disorder*) ) 
OR AB ( intellectual* N1 (disab* or impair* or handicap*) ) OR AB development* N1 disab* OR AB ( 





Appendix B: Flowchart of Study Identification 
 
 
Records identified through database 
searching 
(n =  1332 ) 
Records after duplicates removed 
(n =  1099 ) 
Selected based on abstract 
and title (n =144) screened 
(n =   ) 
Excluded based on abstract and title (n=955) 
(n =   ) 
Articles assessed as  eligible 
for inclusion 
(n = 32 ) 
Articles identified from citations 
(n = 16  ) 
Studies included in tabulation 
(n = 48  ) 
Studies included in meta-
analysis 
(n =  46 ) 
 
Duplicates (n = 233) 
Excluded following consideration of full 
text (n = 112) 
